Latest News

Biogen pulls controversial Alzheimer's drug Aduhelm
Biogen pulls controversial Alzheimer's drug Aduhelm
Economy
by  AFP

A controversial Alzheimer's drug that was trumpeted as the first to ever treat the cognitive decline associated with the devastating brain disorder has been pulled from the market, its maker Biogen announced Wednesday. It showed a reduction in cognitive decline in one of the studies, but not the other.

UK opposition Labour courts business before election
UK opposition Labour courts business before election
Economy
by  AFP

With a UK general election looming, the country's main opposition Labour party is starting to persuade business and financial sector leaders that it can be trusted to grow the economy. UK business remains hampered by high inflation and stagnant growth.